会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 12. 发明申请
    • Plasmid having a function of t-vector and expression vector, and expression of the target gene using the same
    • 具有t载体和表达载体的功能的质粒以及使用其的靶基因的表达
    • US20060199185A1
    • 2006-09-07
    • US10564880
    • 2003-12-31
    • Young SongHaryoung PooMoon-Hee SungSeung-Pyo HongYoon Ho ChoiKwang KimIl Han LeeJe Hyun Park
    • Young SongHaryoung PooMoon-Hee SungSeung-Pyo HongYoon Ho ChoiKwang KimIl Han LeeJe Hyun Park
    • C40B40/02C40B40/08C12Q1/68C12N15/74
    • C12N15/64
    • The present invention relates to a plasmid (pHCE-FOREX) functioning as both a T-vector and an expression vector, which is produced by imparting a T-vector function to an HCE promoter derived from a constitutive high-level expression vector and can express a target protein in a simple and rapid manner. Also, the present invention relates to an expression vector having the target gene inserted into the plasmid, and the expression of the target gene using the same. The plasmid of the present invention can be converted into a vector that expresses the target protein by one-step T-vector cloning in a simple and rapid manner. The plasmid converted into the expression vector does not require a re-transformation step and allows the high-level expression of the target protein only by the culturing of transformed E. coli without the addition of an expensive inducer. Thus, according to the present invention, expression plasmids for large amounts of target genes can be produced at the same time, so that the present invention will be very efficient in establishing expression systems for certain genomes and gene groups.
    • 本发明涉及用作T载体和表达载体两者的质粒(pHCE-FOREX),其通过赋予来自组成型高水平表达载体的HCE启动子产生T载体功能而产生,并可表达 目标蛋白以简单快速的方式。 此外,本发明涉及将靶基因插入质粒的表达载体,以及使用该表达载体的靶基因的表达。 本发明的质粒可通过简单快速的一步T载体克隆转化为表达靶蛋白的载体。 转化成表达载体的质粒不需要再转化步骤,并且仅通过培养转化的大肠杆菌而不添加昂贵的诱导物才允许靶蛋白的高水平表达。 因此,根据本发明,可以同时生产大量靶基因的表达质粒,从而本发明在建立某些基因组和基因组的表达系统方面将非常有效。
    • 18. 发明申请
    • Composition for Adjuvant Containing Poly-Gamma-Glutamic Acid
    • 含有多糖 - 谷氨酸的佐剂组合物
    • US20080152615A1
    • 2008-06-26
    • US11817021
    • 2005-12-06
    • Moon-Hee SungChul-Joong KimHa Ryoung PooSeung Pyo HongJong Soo LeeJi Youn Kim
    • Moon-Hee SungChul-Joong KimHa Ryoung PooSeung Pyo HongJong Soo LeeJi Youn Kim
    • A61K39/02A61K39/12
    • A61K39/39A61K2039/55516
    • The present invention relates to a composition for an immunopotentiator (adjuvant) containing poly-gamma-glutamic acid and a composition for a vaccine containing the immunopotentiator, and more particularly, to an immunopotentiator containing poly-gamma-glutamic acid capable of enhancing antibody production rate by administering it to an animal together with antigen having low immunogenicity, and a composition for a vaccine containing the immunopotentiator and antigen. The inventive adjuvant has almost no toxicity and side effects, and show high antibody titer even when it is used with antigen having poor immunogenicity, so it can be used by adding to medical composition including preventive or curative vaccine for non-contagious chronic diseases as well as cancer, especially prostatic carcinoma, colon carcinoma, lung cancer, breast cancer, ovarian cancer, head and neck cancer, pudendum cancer, bladder cancer, brain tumor and glioma.
    • 本发明涉及含有聚-γ-谷氨酸的免疫增强剂(佐剂)组合物和含有免疫增强剂的疫苗组合物,更具体地说,涉及含有能够提高抗体产生率的聚-γ-谷氨酸的免疫增强剂 通过将其与抗免疫原性低的抗原一起施用于动物,以及含有免疫增强剂和抗原的疫苗组合物。 本发明的佐剂几乎没有毒副作用,即使与抗免疫原性差的抗原一起使用也显示出高的抗体效价,因此可以通过添加包含用于非传染性慢性疾病的预防或治疗性疫苗的医药组合物 作为癌症,特别是前列腺癌,结肠癌,肺癌,乳腺癌,卵巢癌,头颈癌,pudendum癌,膀胱癌,脑肿瘤和胶质瘤。